Tempest Therapeutics, Inc (TPST) insider trading
Every open-market stock purchase and sale by Tempest Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $1M over the last 12 months (2 buys).
- Last insider buy: Matthew Angel (CEO), $500K, 6 months ago.
Last 12 months: insiders bought $1M (2 buys) and sold $0 (0 sales). Last close $1.27 on Jun 7, 2026.
Recent TPST insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | William Drake Richey (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | John D. Yee (Insider) | Bought (not open market) | — |
| Mar 31, 2026 | Justin Trojanowski (Insider) | Bought (not open market) | — |
| Mar 31, 2026 | Nicholas Maestas (CFO) | Bought (not open market) | — |
| Mar 24, 2026 | Matthew Angel (CEO) | Bought | $500K |
| Mar 24, 2026 | Matthew Angel (CEO) | Bought | $500K |
| Feb 4, 2026 | Matthew Angel (CEO) | Bought (not open market) | — |
| Jan 27, 2026 | Ronit Simantov (Insider) | Bought (not open market) | — |
| Jan 27, 2026 | Michael Raab (Insider) | Bought (not open market) | — |
| Jan 27, 2026 | Christine A Pellizzari (Insider) | Bought (not open market) | — |
| Jan 27, 2026 | Geoffrey Nichol (Insider) | Bought (not open market) | — |
Who's trading TPST
- John D. Yee, Insider: other filings, last Jun 4, 2026
- William Drake Richey, Insider: other filings, last Jun 4, 2026
- Nicholas Maestas, CFO: other filings, last Mar 31, 2026
- Justin Trojanowski, Insider: other filings, last Mar 31, 2026
- Matthew Angel, CEO: bought $1M (2 buys), last Mar 24, 2026
- Michael Raab, Insider: other filings, last Jan 27, 2026
- Ronit Simantov, Insider: other filings, last Jan 27, 2026
- Geoffrey Nichol, Insider: other filings, last Jan 27, 2026
- Christine A Pellizzari, Insider: other filings, last Jan 27, 2026
Get free alerts when an insider at Tempest Therapeutics, Inc files a new trade →